ASCO 2022
ASCO 2022
Advertisement
Rob DillardASCO 2022 | August 5, 2022
Older adults with acute myeloid leukemia (AML) treated with hypomethylating agents (HMAs) have more time at home (TAH), ...
Read More
Rob DillardASCO 2022 | October 16, 2023
A study examined the clinical use of ultra-deep next-generation sequencing measurable residual disease (NGS-MRD) before ...
Rob DillardASCO 2022 | October 16, 2023
Researchers of a study sought to discern causes of treatment failure and early mortality in acute myeloid leukemia (AML) ...
Rob DillardASCO 2022 | August 5, 2022
Researchers assessed the incidence and clinical outcomes of non-ischemic or dilated cardiomyopathies in LVAD patients ...
DocWire News EditorsASCO 2022 | April 3, 2023
In a meta-analysis presented at the 2022 American Society of Clinical Oncology Annual Meeting, researchers evaluated ...
DocWire News EditorsASCO 2022 | October 16, 2023
According to research presented at the 2022 American Society of Clinical Oncology Annual Meeting, graft-versus-host ...
DocWire News EditorsASCO 2022 | August 25, 2023
Hispanic patients had a significantly lower cumulative incidence of chronic graft-versus-host disease (GVHD) than ...
DocWire News EditorsASCO 2022 | October 16, 2023
The first-in-human, phase I clinical trial of ADI-001, an allogeneic gamma delta chimeric antigen receptor (CAR) T-cell ...
DocWire News EditorsASCO 2022 | September 26, 2023
A study presented at the 2022 American Society of Clinical Oncology Annual Meeting reported on results of a literature ...
DocWire News EditorsASCO 2022 | October 16, 2023
Patients who received an allogeneic hematopoietic stem cell transplant (HSCT) from matched related donors (MRD) or ...
DocWire News EditorsASCO 2022 | September 21, 2023
A study presented at the 2022 American Society of Clinical Oncology Annual Meeting found that an autologous CD7 chimeric ...
DocWire News EditorsASCO 2022 | October 16, 2023
A retrospective study found that partially mismatched blood or marrow transplantation with post-transplantation ...
Rob DillardASCO 2022 | July 11, 2022
A study assessed autologous CD7 CAR-T therapy in refractory or relapsed r/r T-cell acute lymphoblastic leukemia/lymphoma ...
Rob DillardASCO 2022 | July 11, 2022
Researchers reported updated results from a phase I trial of donor-derived CD7 chimeric antigen receptor (CAR) T cells ...
Rob DillardASCO 2022 | October 16, 2023
Researchers assessed the Charlson comorbidity index (CCI) as a predictor of early mortality and overall survival (OS) in ...
Rob DillardASCO 2022 | July 11, 2022
Researchers from a study presented at the 2022 American Society of Clinical Oncology Annual Meeting identified ...
Rob DillardASCO 2022 | August 30, 2023
A recent analysis shows that shallow whole-genome sequencing (sWGS) is an accurate, convenient, and cost-effective ...
Rob DillardASCO 2022 | August 30, 2023
Researchers conducted a study to discern clinical predictors for the development of venous thromboembolism (VTE) in ...
Rob DillardASCO 2022 | August 24, 2023
The use of machine learning methods is a viable option for identifying patients with myelodysplastic syndrome (MDS), ...
Rob DillardASCO 2022 | October 16, 2023
Chronic myelomonocytic leukemia (CMML) is a heterogenous blood cancer which exhibits features similar to ...
Advertisement
Advertisement
Advertisement
Latest News

May 23, 2024